Cell kinetics in leukemia. Correlation with clinical features and response to chemotherapy.
D001853:Bone Marrow / Q000473:pathology; D001854:Bone Marrow Cells; D003561:Cytarabine / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000096:biosynthesis; D003630:Daunorubicin / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006801:Humans; D007700:Kinetics; D002955:Leucovorin / Q000627:therapeutic use; D007938:Leukemia / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology*; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000473:pathology; D007951:Leukemia, Myeloid / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D015470:Leukemia, Myeloid, Acute / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D008727:Methotrexate; D008940:Mitotic Index; D013866:Thioguanine / Q000627:therapeutic use
D004273:DNA, Neoplasm; D003561:Cytarabine; D013866:Thioguanine; D002955:Leucovorin; D008727:Methotrexate; D003630:Daunorubicin